Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000522539 | SCV000619544 | pathogenic | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV001857990 | SCV002229312 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2024-02-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys1042*) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CEP290-related conditions. ClinVar contains an entry for this variant (Variation ID: 450915). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003470654 | SCV004216510 | likely pathogenic | Bardet-Biedl syndrome 14 | 2023-10-02 | criteria provided, single submitter | clinical testing |